Conclusions of the General Assembly of the ETP Nanomedicine 16/01/2008, UCB Center, Brussels

• After the welcome speech of Mr. Roch Doliveux, CEO of UCB Belgium, the vice-chairs of the ETP: Paul Smit from Philips Healthcare and Jan Hösche from Siemens Healthcare introduced the General Assembly (GA) of the ETP Nanomedicine 2008.

• Patrick Boisseau made a presentation about the most recent updates on the workplan for 2008. The updating of the Terms of Reference (ToR) was consequently voted by the Assembly to include the latest necessary amendments. Most importantly, this was the inclusion of the ETP Office and the membership fee system adopted at the previous GA in September 2007 at Chalkidiki. It was reported that the ETP Office and website are expected to be launched in summer 2008. Further, the new order of assemblies was approved by the GA: from now on there will be normally only one general and one technical assembly annually. The next Working Group (WG) assembly is set to be held in Madrid, September 2008.

• A presentation was given by Uta Faure on the current European Commission (EC) calls for proposals in the area of nanomedicine, including advice on best practice for submitting proposals. This was followed by an extensive Q&A session on the same topic. Ways of input into the EC annual work programmes were also discussed.

• Several technical issues of membership were clarified. The main ones were: - The basic organisational unit for membership is flexible, but the member representative must be in possession of legal authorisation by the member organisation. This will be implemented at the time of first sending the membership fee invoices by the ETP Office, which will also require the declaration of organisation type and name of the authorised representative. - Staff of member organisations other than the authorised representative may attend ETP meetings as observers, within reasonable numbers and subject to prior written notification to the ETP Office. Participation in the different working groups is possible without being a member, but only upon invitation of the WG Chair (ToR §1. ETP Membership).

• The WG Workshops discussed the proposed topics for the update of the SRA and those which should be put forward by the ETP as suggestions to the EC for inclusion in the next years' annual Work Programmes. The member organisations introduced themselves to the WGs as basis for the ensueing networking session. Summaries of the WG Workshops were circulated to the WG members shortly after the GA.

• Slides of the agenda presentations were circulated to the ETP members shortly after the GA.

Participants of the General Assembly

Members of the ETP Nanomedicine Executive Board: Mike Eaton, UCB; Jan Hösche, Siemens Healthcare; Paul Smit, Philips Healthcare; and Uta Faure from the EC

The host Roch Doliveux,

CEO, UCB Belgium

Uta Faure presenting results of 2007 Nanomedicine calls and overview of open calls for 2008

Patrick Boisseau presenting the Workplan 2008 update and the implementation of

previous GA decisions

Kostas Kiparissides presenting the FP6 project NANOBIOPHARMACEUTICS

Daniel Schmitt presenting the FP6 project

CELLPROM